The Role of Antiovarian Autoantibodies in Polycystic Ovary Syndrome

Mary Maher Shoukry;

Abstract


SUMMARY AND CONCLUSION
P
olycystic ovary syndrome is the most common endocrine disorder in women of child-bearing age. It is typically identified during the early reproductive years or adolescence. Worldwide, PCOS affects 6–10% of women. The main underlying endocrinopathies related to PCOS are hyperandrogenism and impaired glucose tolerance secondary to insulin resistance. Also, Women with PCOS display abnormal patterns of gonadotropin pulsatility, which is characterised by excessive secretion of LH but normal secretion of follicle-stimulating hormone (FSH). This pattern of secretion gives rise to an abnormal circulating LH to FSH ratio in some patients.
Genetic, hormonal and Environmental factors play crucial role in the pathogenesis of PCOS. Autoimmunity has been proposed in the pathogenesis of PCOS since early 1990s as several authors have reported association between PCOS and certain autoimmune disorders, including autoimmune thyroiditis, chronic lymphocytic thyroiditis, diabetes mellitus, and even autoimmune oophoritis and premature ovarian failure. The link between PCOS and autoimmunity has been the question of recent studies and reviews.


Other data

Title The Role of Antiovarian Autoantibodies in Polycystic Ovary Syndrome
Other Titles دورالأجسام الذاتية المضادة للمبيض في متلازمة المبيض المتعدد الكيسات
Authors Mary Maher Shoukry
Issue Date 2017

Attached Files

File SizeFormat
J3260.pdf318.52 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 4 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.